Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
4.750
+0.110 (2.37%)
At close: Nov 22, 2024, 4:00 PM
4.900
+0.150 (3.16%)
After-hours: Nov 22, 2024, 7:30 PM EST
Relay Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 10.01 | 25.55 | 1.38 | 3.03 | 82.65 | - | Upgrade
|
| Revenue Growth (YoY) | -61.22% | 1749.82% | -54.41% | -96.34% | - | - | Upgrade
|
| Cost of Revenue | 324.88 | 326.39 | 243.01 | 169.39 | 96.59 | - | Upgrade
|
| Gross Profit | -314.87 | -300.84 | -241.62 | -166.36 | -13.94 | - | Upgrade
|
| Selling, General & Admin | 80.09 | 78.58 | 69.33 | 59.75 | 41.86 | 16.96 | Upgrade
|
| Research & Development | - | - | - | - | - | 67.09 | Upgrade
|
| Operating Expenses | 80.09 | 78.58 | 69.33 | 59.75 | 41.86 | 84.05 | Upgrade
|
| Operating Income | -394.96 | -379.42 | -310.95 | -226.11 | -55.8 | -84.05 | Upgrade
|
| Interest & Investment Income | 34.47 | 31.05 | 8.79 | 0.83 | 3.4 | 8.8 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | -0.02 | -0.02 | -0 | -0.02 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | -360.47 | -348.4 | -302.19 | -225.28 | -52.41 | -75.31 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.9 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -11.86 | - | - | Upgrade
|
| Other Unusual Items | 15.27 | 6.42 | 11.68 | -2.84 | - | - | Upgrade
|
| Pretax Income | -345.2 | -341.97 | -290.51 | -363.87 | -52.41 | -75.31 | Upgrade
|
| Net Income | -345.2 | -341.97 | -290.51 | -363.87 | -52.41 | -75.31 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 177.79 | - | Upgrade
|
| Net Income to Common | -345.2 | -341.97 | -290.51 | -363.87 | -230.2 | -75.31 | Upgrade
|
| Shares Outstanding (Basic) | 132 | 123 | 112 | 95 | 43 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 132 | 123 | 112 | 95 | 43 | 3 | Upgrade
|
| Shares Change (YoY) | 8.66% | 9.22% | 17.97% | 123.22% | 1135.17% | 38.84% | Upgrade
|
| EPS (Basic) | -2.61 | -2.79 | -2.59 | -3.82 | -5.40 | -21.82 | Upgrade
|
| EPS (Diluted) | -2.61 | -2.79 | -2.59 | -3.82 | -5.40 | -21.82 | Upgrade
|
| Free Cash Flow | -282.56 | -304.44 | -238.55 | -77.88 | -104.42 | -74.14 | Upgrade
|
| Free Cash Flow Per Share | -2.14 | -2.48 | -2.13 | -0.82 | -2.45 | -21.49 | Upgrade
|
| Gross Margin | - | - | - | - | -16.86% | - | Upgrade
|
| Operating Margin | -3947.21% | -1485.25% | -22516.44% | -7464.74% | -67.51% | - | Upgrade
|
| Profit Margin | -3449.92% | -1338.66% | -21036.13% | -12012.94% | -278.51% | - | Upgrade
|
| Free Cash Flow Margin | -2823.94% | -1191.74% | -17273.86% | -2571.05% | -126.33% | - | Upgrade
|
| EBITDA | -389.45 | -374.15 | -306.82 | -222.18 | -52.25 | -81.2 | Upgrade
|
| EBITDA Margin | - | - | - | - | -63.21% | - | Upgrade
|
| D&A For EBITDA | 5.51 | 5.27 | 4.13 | 3.93 | 3.55 | 2.85 | Upgrade
|
| EBIT | -394.96 | -379.42 | -310.95 | -226.11 | -55.8 | -84.05 | Upgrade
|
| EBIT Margin | - | - | - | - | -67.51% | - | Upgrade
|
| Revenue as Reported | 10.01 | 25.55 | 1.38 | 3.03 | 82.65 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.